Clinical Trials Directory

Trials / Unknown

UnknownNCT01188330

Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival

Randomized Study Comparing the Interest of a Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival of Elderly Patients With Acute Myeloid Leukaemia. MLSP/IPC 2009-003

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

Acute myeloid leukaemia (AML) is a disease of the elderly, with a median age at diagnosis of 65. A poor outcome in this population has been well established, with very short overall survival (OS) and disease free survival (DFS).There are numerous bad prognostic factors related to the disease itself or to the patient's medical condition. This study will evaluate the impact of a Comprehensive Geriatric assessment (CGA) performed at diagnosis with planned interventions according to disabilities and monthly follow-up by a nurse practitioner during 6 months on functional status of older cancer patients treated for Acute myeloid leukaemia. Functional status will be assessed with the Lawson Instrumental Activities of Daily Living (IADL) scale at diagnosis and 6 months after randomisation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWITH Comprehensive Geriatric assessmentEach month after randomization, a nurse practitioner will systematically review the intervention plan. In case of hospitalisation, the nurse will go and meet the patient and his care giver to check each point of the intervention plan. If an action has not been done, a new proposal will be made to the patient. If the patient is at home or in institution, the nurse practitioner will call the patient and /or his care giver for the same purpose
BEHAVIORALConventionalno Comprehensive Geriatric assessment

Timeline

Start date
2010-03-01
Primary completion
2016-09-01
First posted
2010-08-25
Last updated
2013-10-31

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01188330. Inclusion in this directory is not an endorsement.